{"schema_version":"secwatch.filing_event.v1","accession":"0000897101-24-000562","form_type":"8-K","ticker":"ELMD","cik":"0001488917","company_name":"Electromed, Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.569110+00:00","generated_at":"2026-05-30T01:46:12.016546+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Electromed Q1 FY2025 revenue up 19% to $14.7M; net income $1.5M vs $0.2M YoY","bullets":["Diluted EPS $0.16 vs $0.02 prior year; operating income $1.9M (13.2% rev) vs $0.1M.","Gross margin improved to 78.3% from 77.1%; direct homecare revenue rose 18.5% to $13.2M.","Repurchased 262,756 shares for ~$4.5M at avg $17.26; $0.5M remaining on $5M authorization.","Direct sales force of 53 reps; hired VP Marketing Peter Horwich; launched Triple Down on Bronchiectasis campaign.","Cash $13.9M, no debt; annualized homecare revenue per rep $985,000 (within $900k-$1M target)."],"urls":{"canonical":"https://secwatch.observer/filing/0000897101-24-000562","json":"https://secwatch.observer/filing/0000897101-24-000562.json","markdown":"https://secwatch.observer/filing/0000897101-24-000562.md","text":"https://secwatch.observer/filing/0000897101-24-000562.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1488917/000089710124000562/0000897101-24-000562-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1488917/000089710124000562/elmd241175_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:46:12.016546+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}